Skip to main content
Journal cover image
Comprehensive Dermatologic Drug Therapy, Fourth Edition

Dapsone

Publication ,  Chapter
Bhatia, SM; Hall, RP
January 1, 2020

Dapsone is a sulfonamide derived antibiotic that is a mainstay of therapy for leprosy and Pneumocystis jirovecii infection. This chapter will however focus on its use in numerous inflammatory skin diseases. Dapsone is highly effective in the management of inflammatory dermatosis with a predominant neutrophilic infiltrate, such as dermatitis herpetiformis. Although dapsone has many pharmacologic and idiosyncratic adverse events, a complete understanding of the drug's pharmacology as well as proposed mechanisms of action, will allow the clinician to use maximize the therapeutic benefit of dapsone and minimize the likelihood of significant adverse events.

Duke Scholars

DOI

ISBN

9780323612128

Publication Date

January 1, 2020

Start / End Page

222 / 233.e4
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bhatia, S. M., & Hall, R. P. (2020). Dapsone. In Comprehensive Dermatologic Drug Therapy, Fourth Edition (pp. 222-233.e4). https://doi.org/10.1016/B978-0-323-61211-1.00020-6
Bhatia, S. M., and R. P. Hall. “Dapsone.” In Comprehensive Dermatologic Drug Therapy, Fourth Edition, 222-233.e4, 2020. https://doi.org/10.1016/B978-0-323-61211-1.00020-6.
Bhatia SM, Hall RP. Dapsone. In: Comprehensive Dermatologic Drug Therapy, Fourth Edition. 2020. p. 222-233.e4.
Bhatia, S. M., and R. P. Hall. “Dapsone.” Comprehensive Dermatologic Drug Therapy, Fourth Edition, 2020, pp. 222-233.e4. Scopus, doi:10.1016/B978-0-323-61211-1.00020-6.
Bhatia SM, Hall RP. Dapsone. Comprehensive Dermatologic Drug Therapy, Fourth Edition. 2020. p. 222-233.e4.
Journal cover image

DOI

ISBN

9780323612128

Publication Date

January 1, 2020

Start / End Page

222 / 233.e4